Weymouth Design Wins Best Biotechnology/ Pharmaceuticals Website at the 2005 MITX Awards
Nabi Biopharmaceuticals Website Recognized as Best in Interactive Technologies.
Boston, MA, (PRWEB) November 10, 2005 -- Weymouth Design’s work on Nabi Biopharmaceuticals’ website redesign (www.nabi.com) has been selected as the winner in the category of Biotechnology/Pharmaceuticals by the 2005 MITX Awards. The annual MITX Awards is the largest awards competition in the country that recognizes achievements in the development and implementation of interactive technologies.
Nabi Biopharmaceuticals’ redesigned site is a crucial vehicle for continually relaying key developments to constituents including patients, physicians, media and investors. “By clearly articulating the essence of the Nabi Biopharmaceuticals’ brand, leveraging cutting-edge technology, design, photography, animation and video, we believe that the website provides a strong and lasting impression of Nabi Biopharmaceuticals,” said Tom Kraft, a Director of Interactive Media for Weymouth Design.
Weymouth Design, in partnership with Feinstein Kean Healthcare, redesigned the website. Weymouth Design provided creative concepts, art direction, interface design and development, audio and video production and post production, photography, rich-media, animation, and content management. Feinstein Kean Healthcare, a life science communications consulting firm, provided content, writing and strategic direction.
About Weymouth Design
Weymouth Design has a 32-year track record of effectiveness working with clients ranging from start-ups to Fortune 500 companies on corporate communications and corporate and brand identity. The firm's clients include a range of life sciences, technology/industrial, professional/financial services and consumer/retail companies. The award-winning firm has expertise in: branding, content management, investor presentations, photography, print design, rich media, video, and website design and development. Weymouth Design has studios in Boston and San Francisco.
Contact:
Graham Schelter
Weymouth Design
www.weymouthdesign.com
617. 259. 1421
About Feinstein Kean Healthcare
Feinstein Kean Healthcare, a wholly owned subsidiary of Ogilvy Public Relations Worldwide, specializes in integrated corporate and product communications for life sciences and healthcare companies and organizations. The firm's portfolio of clients includes the full spectrum of emerging therapeutic and technology platform companies; four of the world's five largest pharmaceutical companies; government agencies; and policy organizations. For more information about FKH, visit: www.fkhealth.com.
Contact:
Francesca T. DeVellis
Sr. Vice President
Feinstein Kean Healthcare
www.fkhealth.com
617-577-8110
# # #
|
